Amgen Inc (NASDAQ:AMGN)

152.26
Data as of Jan 30
 -4.11 / -2.63%
Today’s Change
108.20
Today|||52-Week Range
173.14
-4.41%
Year-to-Date
Big Pharma: An Up-Close Look at One Key Player
Jan 31 / MotleyFool.com
Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog
Jan 23 / Zacks.com
Can You Guess What Legal Drug Outsells the NFL?
Jan 31 / MotleyFool.com
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog
Jan 22 / Zacks.com
3 Biotech Giants That Shouldn't Pay a Dividend
Jan 31 / MotleyFool.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog
Jan 22 / Zacks.com
Amgen (AMGN) Stock Declines Today Despite Earnings Beat
Jan 28 / TheStreet.com
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
Jan 22 / Zacks.com
Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog
Jan 28 / Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog
Jan 22 / Zacks.com
Frontrunning: January 28
Jan 28 / Investing Channel
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog
Jan 22 / Zacks.com
Amgen (AMGN) Earnings Report: Q4 2014 Conference Call Transcript
Jan 28 / TheStreet.com
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
Jan 21 / Zacks.com
Amgen, Inc. Earnings: 1 Sentence That Tells You Everything You Need to Know
Jan 27 / MotleyFool.com
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog
Jan 21 / Zacks.com
Amgen Beats Q4 Expectations
Jan 27 / Benzinga
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog
Jan 21 / Zacks.com
Amgen (AMGN) Stock Rises in After-Hours Trading Today on Fourth-Quarter Earnings Beat
Jan 27 / TheStreet.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog
Jan 21 / Zacks.com
Trade-Ideas: Amgen (AMGN) Is Today's Post-Market Leader Stock
Jan 27 / TheStreet.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinica...
Jan 21 / Zacks.com
What to Expect When Amgen (AMGN) Reports Fourth-Quarter Earnings After Market Close T...
Jan 27 / TheStreet.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog
Jan 20 / Zacks.com
Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog
Jan 27 / Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog
Jan 20 / Zacks.com
It's a Crucial Moment for This Market
Jan 27 / TheStreet.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog
Jan 20 / Zacks.com
We Need Better Earnings Reports
Jan 27 / TheStreet.com
J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog
Jan 20 / Zacks.com
Earnings Scheduled For January 27, 2015
Jan 27 / Benzinga
Can AbbVie Inc. Overcome Humirabs Looming Patent Expiration?
Jan 20 / MotleyFool.com
5 Big Biotech Earnings Releases To Watch This Week
Jan 26 / Benzinga
AbbVie Gains EU Approval for Hepatitis C Virus Treatment - Analyst Blog
Jan 19 / Zacks.com
TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog
Jan 26 / Zacks.com
These Stocks' Dividends Could Soar in 2015
Jan 18 / MotleyFool.com
These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales
Jan 25 / MotleyFool.com
How to Invest in an Aging America
Jan 18 / MotleyFool.com
These 3 Dividend Stocks Could Crush the Market in 2015
Jan 24 / MotleyFool.com
Kyle Bass plans legal action on pharma patents
Jan 07 / FT.com
Will Amgen (AMGN) Keep the Earnings Streak Alive in 4Q? - Analyst Blog
Jan 23 / Zacks.com
FDA paves way for biosimilar drug approval
Jan 06 / FT.com

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.